Despite steady revenue growth and low valuations, Sotera stock has been hit hard by recent litigation challenges. Read more to see if SHC stock is now oversold.
Agios Pharmaceuticals has garnered one recent FDA approval and has five other pivotal trials underway. Click here to read a full analysis of AGIO stock.
Shares of real estate franchisor RE/MAX Holdings are down over 60% since reaching an all-time high in 2017, including roughly 20% YTD22 as previously absurd valuations have rationalized.